Items where authors include "Jaki, T."

Export as [feed] Atom [feed] RSS
Number of items: 18.

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Yap, C. orcid.org/0000-0002-6715-2514, Rekowski, J. orcid.org/0000-0002-5207-3864, Ursino, M. orcid.org/0000-0002-5709-4322 et al. (32 more authors) (2023) Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT dose-finding extension (SPIRIT-DEFINE) guidance. BMJ, 383. e076386. ISSN 1759-2151

Yap, C. orcid.org/0000-0002-6715-2514, Solovyeva, O. orcid.org/0000-0001-7828-4099, de Bono, J. orcid.org/0000-0002-2034-595X et al. (32 more authors) (2023) Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT dose-finding extension (CONSORT-DEFINE) guidance. BMJ, 383. e076387. ISSN 0959-8138

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Solovyeva, O. orcid.org/0000-0001-7828-4099, Dimairo, M. orcid.org/0000-0002-9311-6920, Weir, C.J. orcid.org/0000-0002-6494-4903 et al. (20 more authors) (2023) Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study. BMC Medicine, 21 (1). 246. ISSN 1741-7015

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Robertson, D.S. orcid.org/0000-0001-6207-0416, Choodari‐Oskooei, B. orcid.org/0000-0001-7679-5899, Dimairo, M. orcid.org/0000-0002-9311-6920 et al. (3 more authors) (2023) Point estimation for adaptive trial designs II: practical considerations and guidance. Statistics in Medicine. ISSN 0277-6715

Espinasse, A. orcid.org/0000-0002-1271-302X, Solovyeva, O., Dimairo, M. orcid.org/0000-0002-9311-6920 et al. (13 more authors) (2023) SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol. BMJ Open, 13. e068173. ISSN 2044-6055

Robertson, D.S., Choodari‐Oskooei, B., Dimairo, M. orcid.org/0000-0002-9311-6920 et al. (3 more authors) (2022) Point estimation for adaptive trial designs I: a methodological review. Statistics in Medicine. ISSN 0277-6715

Wason, J.M.S., Dimairo, M., Biggs, K. et al. (16 more authors) (2022) Practical guidance for planning resources required to support publicly-funded adaptive clinical trials. BMC Medicine, 20 (1). 254.

Wilson, N., Biggs, K., Bowden, S. et al. (19 more authors) (2021) Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project. BMC Medicine, 19 (1). 251. ISSN 1741-7015

Dimairo, M. orcid.org/0000-0002-9311-6920, Pallmann, P., Wason, J. et al. (16 more authors) (2020) The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design. BMJ, 369. m115. ISSN 1759-2151

Dimairo, M. orcid.org/0000-0002-9311-6920, Pallmann, P., Wason, J. et al. (16 more authors) (2020) The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design. Trials, 21 (1). 528. ISSN 1745-6215

Dimairo, M. orcid.org/0000-0002-9311-6920, Coates, E., Pallmann, P. et al. (16 more authors) (2018) Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design. BMC Medicine, 16. 210. ISSN 1741-7015

Pallmann, P., Bedding, A.W., Choodari-Oskooei, B. et al. (13 more authors) (2018) Adaptive designs in clinical trials: why use them, and how to run and report them. BMC Medicine, 16 (29). ISSN 1741-7015

Proceedings Paper

Dimairo, M. orcid.org/0000-0002-9311-6920, Pallmann, P., Wason, J. et al. (16 more authors) (2019) Introducing the adaptive designs CONSORT extension (ACE) statement to improve reporting of randomised trials that use an adaptive design. In: Trials. 5th International Clinical Trials Methodology Conference (ICTMC 2019), 06-09 Oct 2019, Brighton, UK. BioMed Central , pp. 2-3.

Dimairo, M. orcid.org/0000-0002-9311-6920, Todd, S., Julious, S. et al. (16 more authors) (2017) Journeying through the development of a consensus-driven adaptive designs reporting guidance. In: Conference booklet: Ethics of alternative clinical trial designs and methods in LMIC research. Global Forum on Bioethics in Research, 28-29 Nov 2017, Bangkok, Thailand. GFBR .

This list was generated on Sat Apr 13 22:34:31 2024 BST.